Ipilimumab/Nivolumab Followed by Nivolumab Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of ipilimumab and nivolumab followed by nivolumab that can be used for the treatment of kidney, colorectal, esophageal and esophagogastric junction, gastric, and hepatobiliary cancers, cutaneous and uveal melanoma, ampullary, appendiceal and small bowel adenocarcinoma, well-differentiated grade 3 neuroendocrine tumors (NETs), extrapulmonary poorly differentiated neuroendocrine carcinoma/large or small cell carcinoma/mixed neuroendocrine-non-neuroendocrine neoplasm, and Merkel cell carcinoma.

**Synonyms:** - Ipilimumab/Nivolumab Followed by Nivolumab - Nivolumab/Ipilimumab Followed by Nivolumab - Yervoy/Opdivo Followed by Opdivo